Evidence map›Paper›PMID 38566925›Full record

ReviewFrontiers in medicine2024

Artificial intelligence and skin cancer.

Maria L Wei, Mikio Tada, Alexandra So, Rodrigo Torres

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Using the power of artificial intelligence to improve the diagnosis and management of nonmelanoma skin cancer.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria L WeiDepartment of Dermatology, University of California, San Francisco, San Francisco, CA, United States.
Mikio TadaInstitute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, United States.
Alexandra SoSchool of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Rodrigo TorresDermatology Service, San Francisco VA Health Care System, San Francisco, CA, United States.

Funding

Improving dermatology access by direct-to-patient teledermatology and computer-assisted diagnosisI01HX003473 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DENNIS H OH, MARTIN A. WEINSTOCK · 2021 to 2026
–
HSRD VA I01 HX003473
6 · The paper itself

Abstract

Artificial intelligence is poised to rapidly reshape many fields, including that of skin cancer screening and diagnosis, both as a disruptive and assistive technology. Together with the collection and availability of large medical data sets, artificial intelligence will become a powerful tool that can be leveraged by physicians in their diagnoses and treatment plans for patients. This comprehensive review focuses on current progress toward AI applications for patients, primary care providers, dermatologists, and dermatopathologists, explores the diverse applications of image and molecular processing for skin cancer, and highlights AI's potential for patient self-screening and improving diagnostic accuracy for non-dermatologists. We additionally delve into the challenges and barriers to clinical implementation, paths forward for implementation and areas of active research.

Indexed as

artificial intelligencedermatologydermatopathologymelanomaskin cancer

Identifiers

PMID38566925
PMCPMC10985205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.